These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3520306)

  • 1. Mutagenicity of N-arylacetohydroxamic acids and their O-glucosides derived from chlorinated 4-nitrobiphenyl ethers.
    Yoshioka T; Takou Y; Uematsu T
    Mutat Res; 1986 Jun; 170(3):93-102. PubMed ID: 3520306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic activity of possible metabolites of 4-nitrobiphenyl ether.
    Miyauchi M; Takou Y; Watanabe M; Uematsu T
    Chem Biol Interact; 1984 Sep; 51(1):49-62. PubMed ID: 6378413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
    Wesp HF; Tang X; Edenharder R
    Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and synergistic roles in enzyme-catalyzed regioselective and complete hydrolytic deprotection of O-acetylated β-D-glucopyranosides of N-arylacetohydroxamic acids.
    Baba A; Yoshioka T
    J Org Chem; 2012 Feb; 77(4):1675-84. PubMed ID: 22283641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of chlorinated products from soil humic substances.
    Sato T; Mukaida M; Ose Y; Nagase H; Ishikawa T
    Sci Total Environ; 1985 Nov; 46():229-41. PubMed ID: 3909401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of derivatives and metabolites of 1-nitropyrene: activation by rat liver S9 and bacterial enzymes.
    Ball LM; Kohan MJ; Claxton LD; Lewtas J
    Mutat Res; 1984; 138(2-3):113-25. PubMed ID: 6392870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of some derivatives of dipyrido[1,2-a:3',2'-d]imidazoles in Salmonella typhimurium with metabolic activation by rat liver and small intestine subcellular fractions.
    N'Goy K; Saint-Ruf G; de Meester C
    Mutat Res; 1985; 156(1-2):53-9. PubMed ID: 3889627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic activity of chlorinated 4-nitrobiphenyl ethers and their nitroso- and amino-derivatives.
    Miyauchi M; Haga M; Takou Y; Uematsu T
    Chem Biol Interact; 1983; 44(1-2):133-41. PubMed ID: 6342825
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
    Suter W; Matter-Jaeger I
    Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of amine drugs and their products of nitrosation.
    Andrews AW; Lijinsky W; Snyder SW
    Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic activity of newly synthesized sulfa drugs to Salmonella typhimurium.
    Temcharoen P; Nerapattanakid S; Toskulkao C; Glinsukon T; Paovaro C; Ruchirawat S
    Mutat Res; 1994 Jun; 321(4):187-95. PubMed ID: 7515156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutagenic potential of 25 organophosphinate compounds.
    Sauers LJ; Fruin JT
    Mutat Res; 1982 Nov; 105(5):299-302. PubMed ID: 6755236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the mutagenic activity of some phenanthroisoquinolines in Salmonella typhimurium.
    Tanga MJ; Reist EJ
    Mutat Res; 1988 Oct; 206(2):235-8. PubMed ID: 3050503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of 7H-dibenzo[c,g]carbazole and metabolites in Salmonella typhimurium.
    Schoeny R; Warshawsky D
    Mutat Res; 1987 Aug; 188(4):275-86. PubMed ID: 3302697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
    Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
    Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of N-acetylbenzidine and N,N'-diacetylbenzidine to mutagens, using isolated hepatocytes and the 9000 X g liver supernatant from rat, hamster and guinea pig.
    Neis JM; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1985 Sep; 151(2):195-200. PubMed ID: 3897847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
    Suzuki J; Kobayashi Y; Monden S; Suzuki S
    Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.